Patenting the Microbiome
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? […]
Featured, General Biotechnology
General Biotechnology
Solving the problem of biologic delivery: Large volume wearable injectors
This is a guest post from Michael D. Hooven, President & CEO, Enable Injections Inc. The oxpecker perches on the backs
Solving the problem of biologic delivery: Large volume wearable injectors Read Post »
General Biotechnology, Guest content, Insights
Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory
Hermann A. M. Mucke*, H. M. Pharma Consultancy, Wien, Austria A Multimodal Approach to the Re-development of Drugs Drug repositioning—the investigation, development and use of active pharmaceutical ingredients for a…
The post Drug Repositioning in the …
Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory Read Post »
General Biotechnology
What is in licensing and out licensing in pharmaceutical sector?
These are relative terms. If I license a product from you, I am in-licensing it and you are out-licensing it.
What is in licensing and out licensing in pharmaceutical sector? Read Post »
Patent misuse in the Pharmaceutical sector
This is a guest post from Avneet Heer, a student in the MS Biotechnology BioBusiness Track at Georgetown University. Do
General Biotechnology
Biotech venture capital investments in public equities and performance
How do biotech venture investments in public equities (known as VIPEs) perform? Do they outperform mutual funds and hedge funds?
Biotech venture capital investments in public equities and performance Read Post »
General Biotechnology
Leaving money on the table in venture-backed biotechnology IPOs
How do biotech stocks behave during the first day of trading? How do they perform in the long-run period? What
Leaving money on the table in venture-backed biotechnology IPOs Read Post »
New features from DrugPatentWatch – Bulk API sources and clinical trials
After months of development and feedback from customers, DrugPatentWatch is proud to announce the availability of two new datasets: Bulk
New features from DrugPatentWatch – Bulk API sources and clinical trials Read Post »
General Biotechnology, Guest content
A Brief Patent Primer
This is a guest post from Mark D. Shtilerman1 and Joseph Eng Jr. Dr. Shtilerman is Senior Counsel at Deerfield
Biotech in Countries Starting with “I” – Part 11: Italy (secondo)
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
Biotech in Countries Starting with “I” – Part 11: Italy (secondo) Read Post »